The Visions PV .014P digital IVUS catheter provides vessel imaging, an essential approach for the diagnosis and treatment of coronary and peripheral vasculature. Philips Image Guided Therapy Devices peripheral vascular portfolio ensures clinicians feel confident that they’re delivering the best possible care with personalized treatment and … We look forward to working closely with Philips and ensuring a smooth transition and closing.”The board of directors of Volcano has unanimously approved the transaction and recommends the offer to its shareholders. Philips Volcano, a Philips business, is a global leader in physiology and intravascular imaging for coronary and peripheral applications. After seeing the value the images provided me, I took IVUS into the peripheral realm with the legs first and then into dialysis work in the arms. Presently employed at Volcano/Philips corporation.. Clinical Consultant for peripheral and cardiac. The system is not intended for use in the coronary, carotid, iliac or renal ”Volcano’s impressive and unique product portfolio is highly complementary to our strong offering in live image-guidance solutions, creating an opportunity to accelerate the revenue growth for our image-guided therapy business to a high single-digit rate by 2017.
As a result, the transaction is expected to be accretive to Philips’ reported earnings per share by 2017, and Philips targets an EBITA margin for its image-guided therapy business group of around 20% by 2017.December 17, 2014 — Philips Healthcare and Volcano Corp. entered into a definitive merger agreement, where Philips will purchase shares of Volcano for a total price of about $1 billion.The flexible design of the Infinix-i streamlines procedures and allows operators to obtain a wide range of imaging angles without repositioning the patient.Upon completion of the transaction, the Volcano business and its 1,800 employees will be part of a dedicated, new image-guided therapy business group within Philips, which will be led by Philips executive Bert van Meurs, an experienced leader in the health care industry with a proven track record in the image-guided therapy market.“I am very excited that Volcano will become part of Philips and join forces with its leading image guided therapy business,” said Scott Huennekens, Volcano president and CEO. Sales growth will be accelerated through Volcano’s close customer relationships associated with its disposable products and channel synergies that will create cross-selling opportunities between both companies’ existing customer bases. The additional technology will enhance Philips' angiography imaging system suite offerings.
About Royal Philips Royal Philips is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. As an industry leader in the diagnosis and treatment of peripheral vascular disease, Philips Volcano has a responsibility to create broader awareness and understanding of the disease state for the betterment of medical practice and patient care.
Volcano is a leader in intravascular ultrasound (IVUS) and fractional flow reserve (FFR) catheter measurements used in the interventional cardiology cath lab.